218 related articles for article (PubMed ID: 35710135)
1. Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials.
Dambrova M; Makrecka-Kuka M; Kuka J; Vilskersts R; Nordberg D; Attwood MM; Smesny S; Sen ZD; Guo AC; Oler E; Tian S; Zheng J; Wishart DS; Liepinsh E; Schiöth HB
Pharmacol Rev; 2022 Jul; 74(3):506-551. PubMed ID: 35710135
[TBL] [Abstract][Full Text] [Related]
2. Acylcarnitines: role in brain.
Jones LL; McDonald DA; Borum PR
Prog Lipid Res; 2010 Jan; 49(1):61-75. PubMed ID: 19720082
[TBL] [Abstract][Full Text] [Related]
3. Acylcarnitines: potential implications for skeletal muscle insulin resistance.
Aguer C; McCoin CS; Knotts TA; Thrush AB; Ono-Moore K; McPherson R; Dent R; Hwang DH; Adams SH; Harper ME
FASEB J; 2015 Jan; 29(1):336-45. PubMed ID: 25342132
[TBL] [Abstract][Full Text] [Related]
4. Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.
Zhang J; Light AR; Hoppel CL; Campbell C; Chandler CJ; Burnett DJ; Souza EC; Casazza GA; Hughen RW; Keim NL; Newman JW; Hunter GR; Fernandez JR; Garvey WT; Harper ME; Fiehn O; Adams SH
Exp Physiol; 2017 Jan; 102(1):48-69. PubMed ID: 27730694
[TBL] [Abstract][Full Text] [Related]
5. Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease.
Saiki S; Hatano T; Fujimaki M; Ishikawa KI; Mori A; Oji Y; Okuzumi A; Fukuhara T; Koinuma T; Imamichi Y; Nagumo M; Furuya N; Nojiri S; Amo T; Yamashiro K; Hattori N
Sci Rep; 2017 Aug; 7(1):7328. PubMed ID: 28779141
[TBL] [Abstract][Full Text] [Related]
6. Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism.
Houten SM; Wanders RJA; Ranea-Robles P
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165720. PubMed ID: 32057943
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
[TBL] [Abstract][Full Text] [Related]
8. Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency.
Fingerhut R; Ensenauer R; Röschinger W; Arnecke R; Olgemöller B; Roscher AA
Anal Chem; 2009 May; 81(9):3571-5. PubMed ID: 19323528
[TBL] [Abstract][Full Text] [Related]
9. Acylcarnitines in fibroblasts of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency and other fatty acid oxidation disorders.
Shen JJ; Matern D; Millington DS; Hillman S; Feezor MD; Bennett MJ; Qumsiyeh M; Kahler SG; Chen YT; Van Hove JL
J Inherit Metab Dis; 2000 Feb; 23(1):27-44. PubMed ID: 10682306
[TBL] [Abstract][Full Text] [Related]
10. Acylcarnitines--old actors auditioning for new roles in metabolic physiology.
McCoin CS; Knotts TA; Adams SH
Nat Rev Endocrinol; 2015 Oct; 11(10):617-25. PubMed ID: 26303601
[TBL] [Abstract][Full Text] [Related]
11. Acylcarnitines in intermediary metabolism.
Sewell AC; Böhles HJ
Eur J Pediatr; 1995 Nov; 154(11):871-7. PubMed ID: 8582396
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma and milk short-chain acylcarnitine concentrations reflect systemic LPS response in mid-lactation dairy cows.
Xu W; Grindler S; Dänicke S; Frahm J; Kenéz Á; Huber K
Am J Physiol Regul Integr Comp Physiol; 2021 Sep; 321(3):R429-R440. PubMed ID: 34318701
[TBL] [Abstract][Full Text] [Related]
13. The saturation degree of fatty acids and their derived acylcarnitines determines the direct effect of metabolically active thyroid hormones on insulin sensitivity in skeletal muscle cells.
Giacco A; Delli Paoli G; Senese R; Cioffi F; Silvestri E; Moreno M; Ruoppolo M; Caterino M; Costanzo M; Lombardi A; Goglia F; Lanni A; de Lange P
FASEB J; 2019 Feb; 33(2):1811-1823. PubMed ID: 30204501
[TBL] [Abstract][Full Text] [Related]
14. Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.
Reuter SE; Evans AM
Clin Pharmacokinet; 2012 Sep; 51(9):553-72. PubMed ID: 22804748
[TBL] [Abstract][Full Text] [Related]
15. Valproate induces in vitro accumulation of long-chain fatty acylcarnitines.
Silva MF; Jakobs C; Duran M; de Almeida IT; Wanders RJ
Mol Genet Metab; 2001 Aug; 73(4):358-61. PubMed ID: 11509020
[TBL] [Abstract][Full Text] [Related]
16. Lower Concentrations of Circulating Medium and Long-Chain Acylcarnitines Characterize Insulin Resistance in Persons with HIV.
Bailin SS; Jenkins CA; Petucci C; Culver JA; Shepherd BE; Fessel JP; Hulgan T; Koethe JR
AIDS Res Hum Retroviruses; 2018 Jun; 34(6):536-543. PubMed ID: 29607651
[TBL] [Abstract][Full Text] [Related]
17. L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine.
McCann MR; George De la Rosa MV; Rosania GR; Stringer KA
Metabolites; 2021 Jan; 11(1):. PubMed ID: 33466750
[TBL] [Abstract][Full Text] [Related]
18. Hydroxylated Long-Chain Acylcarnitines are Biomarkers of Mitochondrial Myopathy.
Vissing CR; Dunø M; Wibrand F; Christensen M; Vissing J
J Clin Endocrinol Metab; 2019 Dec; 104(12):5968-5976. PubMed ID: 31294795
[TBL] [Abstract][Full Text] [Related]
19. Enterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel Disease.
Lemons JMS; Conrad M; Tanes C; Chen J; Friedman ES; Roggiani M; Curry D; Chau L; Hecht AL; Harling L; Vales J; Kachelries KE; Baldassano RN; Goulian M; Bittinger K; Master SR; Liu L; Wu GD
Cell Mol Gastroenterol Hepatol; 2024; 17(1):131-148. PubMed ID: 37739064
[TBL] [Abstract][Full Text] [Related]
20. Plasma acylcarnitine profiling indicates increased fatty acid oxidation relative to tricarboxylic acid cycle capacity in young, healthy low birth weight men.
Ribel-Madsen A; Ribel-Madsen R; Brøns C; Newgard CB; Vaag AA; Hellgren LI
Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27694528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
